Dare Bioscience, Inc. Share Price
NASDAQ: DARE | Micro Cap$0.68
+$0.68 (--%) Last updated on 30 Oct, 2026 | 01:20 ISTDare Bioscience, Inc. Stock Performance
Dare Bioscience, Inc. Share Price Chart
$0.68$0.68
L
H
Dare Bioscience, Inc. Quarterly Profit & Loss
All figures in USD
Dare Bioscience, Inc. Annual Profit & Loss
All figures in USD
About Dare Bioscience, Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
Dare Bioscience, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $0.83 | $0.68 | -20.63% |
Sep 2026 | $0.76 | $0.85 | +14.50% |
Aug 2026 | $1.27 | $0.74 | -39.43% |
Jul 2026 | $2.16 | $1.23 | -41.71% |
Jun 2026 | $2.24 | $2.11 | -7.46% |
May 2026 | $2.42 | $2.28 | +1.79% |
Apr 2026 | $1.78 | $2.24 | +23.08% |
Mar 2026 | $1.65 | $1.82 | +8.33% |
Feb 2026 | $1.71 | $1.68 | -7.69% |
Jan 2026 | $1.97 | $1.82 | -6.19% |
Dec 2025 | $1.78 | $1.94 | +6.01% |
Nov 2025 | $1.96 | $1.83 | -6.15% |